{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:27:38Z","timestamp":1792297658888,"version":"4.4.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T00:00:00Z","timestamp":1337644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/nrgastro.2012.96","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T04:10:01Z","timestamp":1337659801000},"page":"382-391","source":"Crossref","is-referenced-by-count":86,"title":["Recent advances in our understanding of hepatorenal syndrome"],"prefix":"10.1038","volume":"9","author":[{"given":"Florence","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,22]]},"reference":[{"key":"BFnrgastro201296_CR1","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/hep.22605","volume":"48","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao, G., Parikh, C. R. & Viola A. Acute kidney injury in cirrhosis. Hepatology 48, 2064\u20132077 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR2","first-page":"354","volume-title":"Schiff's Diseases of the Liver","author":"F Wong","year":"2011","unstructured":"Wong, F. in Schiff's Diseases of the Liver 11th edn (eds Schiff, E. R., Maddrey, W. C. & Sorrell, M. F.) 354\u2013371 (Wiley-Blackwell, 2011)."},{"key":"BFnrgastro201296_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.1840080532","volume":"8","author":"R Schrier","year":"1988","unstructured":"Schrier, R.  et al. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8, 1151\u20131157 (1988).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR4","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno, F., Gerbes, A., Gin\u00e8s, P., Wong, F. & Arroyo, V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56, 1310\u20131318 (2007).","journal-title":"Gut"},{"key":"BFnrgastro201296_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","volume":"8","author":"S Montoliu","year":"2010","unstructured":"Montoliu, S.  et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin. Gastroenterol. Hepatol. 8, 616\u2013622 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201296_CR6","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gin\u00e8s","year":"2003","unstructured":"Gin\u00e8s, P., Guevara, M., Arroyo, V. & Rod\u00e9s, J. Hepatorenal syndrome. Lancet 362, 1819\u20131827 (2003).","journal-title":"Lancet"},{"key":"BFnrgastro201296_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1056\/NEJM199808203390807","volume":"339","author":"PY Martin","year":"1998","unstructured":"Martin, P. Y., Gin\u00e8s, P. & Schrier, R. W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N. Engl. J. Med. 339, 533\u2013541 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201296_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1478-3231.2008.01857.x","volume":"29","author":"L Van Landeghem","year":"2009","unstructured":"Van Landeghem, L.  et al. Carbon monoxide produced by intrasinusoidally located haem-oxygenase-1 regulates the vascular tone in cirrhotic rat liver. Liver Int. 29, 650\u2013660 (2009).","journal-title":"Liver Int."},{"key":"BFnrgastro201296_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/gast.2002.30305","volume":"122","author":"J Ros","year":"2002","unstructured":"Ros, J.  et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 122, 85\u201393 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/89953","volume":"7","author":"S B\u00e1tkai","year":"2001","unstructured":"B\u00e1tkai, S.  et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med. 7, 827\u2013832 (2001).","journal-title":"Nat. Med."},{"key":"BFnrgastro201296_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0168-8278(94)80096-0","volume":"21","author":"A Castro","year":"1994","unstructured":"Castro, A.  et al. Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis. J. Hepatol. 21, 521\u2013526 (1994).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1136\/gut.2010.235473","volume":"60","author":"S M\u00f8ller","year":"2011","unstructured":"M\u00f8ller, S., Hobolth, L., Winkler, C., Bendtsen, F. & Christensen, E. Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut 60, 1254\u20131259 (2011).","journal-title":"Gut"},{"key":"BFnrgastro201296_CR13","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.1840200619","volume":"20","author":"A Follo","year":"1994","unstructured":"Follo, A.  et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20, 1495\u20131501 (1994).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/hep.21443","volume":"45","author":"S Fasolato","year":"2007","unstructured":"Fasolato, S.  et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 45, 223\u2013229 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/BF02777753","volume":"27","author":"S Sugano","year":"1992","unstructured":"Sugano, S. Endotoxin levels in cirrhotic rats with sterile and infected ascites. Gastroenterol. Jpn 27, 348\u2013353 (1992).","journal-title":"Gastroenterol. Jpn"},{"key":"BFnrgastro201296_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0168-8278(00)80272-X","volume":"33","author":"J Heller","year":"2000","unstructured":"Heller, J.  et al. Effects of lipopolysaccharide on TNF-\u03b1 production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J. Hepatol. 33, 376\u2013381 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR17","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI7458","volume":"104","author":"R Wiest","year":"1999","unstructured":"Wiest, R.  et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest. 104, 1223\u20131233 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201296_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/jhep.2003.50038","volume":"37","author":"A Albillos","year":"2003","unstructured":"Albillos, A.  et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37, 208\u2013217 (2003).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.gastro.2005.04.016","volume":"129","author":"KA Tazi","year":"2005","unstructured":"Tazi, K. A.  et al. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Gastroenterology 129, 303\u2013314 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR20","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1053\/jhep.2001.27093","volume":"34","author":"P Cejudo-Mart\u00edn","year":"2001","unstructured":"Cejudo-Mart\u00edn, P.  et al. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 34, 487\u2013493 (2001).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.21785","volume":"46","author":"M Fernandez","year":"2007","unstructured":"Fernandez, M.  et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 46, 1208\u20131217 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","volume":"53","author":"J Bosch","year":"2010","unstructured":"Bosch, J., Abraldes, J. G., Fern\u00e1ndez, M. & Garc\u00eda-Pag\u00e1n, J. C. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J. Hepatol. 53, 558\u2013567 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12072-008-9109-7","volume":"3","author":"F Wong","year":"2009","unstructured":"Wong, F. Cirrhotic cardiomyopathy. Hepatol. Int. 3, 294\u2013304 (2009).","journal-title":"Hepatol. Int."},{"key":"BFnrgastro201296_CR24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/hep.20766","volume":"42","author":"L Ruiz-del-Arbol","year":"2005","unstructured":"Ruiz-del-Arbol, L.  et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42, 439\u2013447 (2005).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/gut.2009.180570","volume":"59","author":"A Krag","year":"2010","unstructured":"Krag, A., Bendtsen, F., Henriksen, J. H. & M\u00f8ller, S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 59, 105\u2013110 (2010).","journal-title":"Gut"},{"key":"BFnrgastro201296_CR26","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"L Ruiz-del-Arbol","year":"2003","unstructured":"Ruiz-del-Arbol, L.  et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38, 1210\u20131218 (2003).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","volume":"134","author":"V Stadlbauer","year":"2008","unstructured":"Stadlbauer, V.  et al. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. Gastroenterology 134, 111\u2013119 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","volume":"55","author":"F Salerno","year":"2011","unstructured":"Salerno, F.  et al. Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice. J. Hepatol. 55, 1241\u20131248 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0272-6386(82)80096-6","volume":"2","author":"AK Mandal","year":"1982","unstructured":"Mandal, A. K., Lansing, M. & Fahmy, A. Acute tubular necrosis in hepatorenal syndrome: an electron microscopy study. Am. J. Kidney Dis. 2, 363\u2013374 (1982).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrgastro201296_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","volume":"30","author":"JM Trawal\u00e9","year":"2010","unstructured":"Trawal\u00e9, J. M.  et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int. 30, 725\u2013732 (2010).","journal-title":"Liver Int."},{"key":"BFnrgastro201296_CR31","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1517\/14656566.2011.561200","volume":"12","author":"M Guevara","year":"2011","unstructured":"Guevara, M. & Arroyo, V. Hepatorenal syndrome. Expert Opin. Pharmacother. 12, 1405\u20131417 (2011).","journal-title":"Expert Opin. Pharmacother."},{"key":"BFnrgastro201296_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0016-5085(82)90129-9","volume":"82","author":"J Cabrera","year":"1982","unstructured":"Cabrera, J.  et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary \u03b22-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 82, 97\u2013105 (1982).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1523-1755.1998.00968.x","volume":"54","author":"A Meyrier","year":"1998","unstructured":"Meyrier, A., Hill, G. S. & Simon, P. Ischemic renal diseases: new insights into old entities. Kidney Int. 54, 2\u201313 (1998).","journal-title":"Kidney Int."},{"key":"BFnrgastro201296_CR34","first-page":"9","volume":"71","author":"T Serst\u00e9","year":"2008","unstructured":"Serst\u00e9, T., Lebrec, D., Valla, D. & Moreau, R. Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites. Acta Gastroenterol. Belg. 71, 9\u201314 (2008).","journal-title":"Acta Gastroenterol. Belg."},{"key":"BFnrgastro201296_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCC.0b013e3283455c57","volume":"17","author":"R Jalan","year":"2011","unstructured":"Jalan, R. Acute-on-chronic liver failure: from concept to a new syndrome. Curr. Opin. Crit. Care 17, 152 (2011).","journal-title":"Curr. Opin. Crit. Care"},{"key":"BFnrgastro201296_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MCC.0b013e328344b42d","volume":"17","author":"JC Olsen","year":"2011","unstructured":"Olsen, J. C. & Kamath, P. S. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr. Opin. Crit. Care 17, 165\u2013169 (2011).","journal-title":"Curr. Opin. Crit. Care"},{"key":"BFnrgastro201296_CR37","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/hep.23264","volume":"50","author":"T Gustot","year":"2009","unstructured":"Gustot, T., Durand, F., Lebrec, D., Vincent, J. L. & Moreau, R. Severe sepsis in cirrhosis. Hepatology 50, 2022\u20132033 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-2008-1040323","volume":"28","author":"V Arroyo","year":"2008","unstructured":"Arroyo, V., Fernandez, J. & Gin\u00e8s, P. Pathogenesis and treatment of hepatorenal syndrome. Semin. Liver Dis. 28, 81\u201395 (2008).","journal-title":"Semin. Liver Dis."},{"issue":"Suppl. 2","key":"BFnrgastro201296_CR39","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1016\/S0168-8278(12)60666-7","volume":"56","author":"W Leung","year":"2012","unstructured":"Leung, W., Al Beshir, M., Marquez, M., Renner, E. & Wong, F. Is type 1 hepatorenal syndrome reversible after liver transplantation? [abstract 653]. J. Hepatol. 56 (Suppl. 2), S258\u2013S259 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1478-3231.2008.01877.x","volume":"29","author":"R Terg","year":"2009","unstructured":"Terg, R.  et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int. 29, 415\u2013419 (2009).","journal-title":"Liver Int."},{"key":"BFnrgastro201296_CR41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/gut.2006.113050","volume":"56","author":"SH Sigal","year":"2007","unstructured":"Sigal, S. H., Stanca, C. M., Fern\u00e1ndez, J., Arroyo, V. & Navasa, M. Restricted use of albumin for spontaneous bacterial peritonitis. Gut 56, 597\u2013599 (2007).","journal-title":"Gut"},{"key":"BFnrgastro201296_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cgh.2011.11.012","volume":"10","author":"M Poca","year":"2012","unstructured":"Poca, M.  et al. Role of albumin in the treatment in patients with spontaneous bacterial peritonitis. Clin. Gastroenterol. Hepatol. 10, 309\u2013315 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201296_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort, P.  et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med. 341, 403\u2013409 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201296_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2036.2011.04746.x","volume":"34","author":"NC Chavez-Tapia","year":"2011","unstructured":"Chavez-Tapia, N. C.  et al. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding\u2014an updated Cochrane review. Aliment. Pharmacol. Ther. 34, 509\u2013518 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201296_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1586\/17474124.1.2.207","volume":"1","author":"FH Saner","year":"2007","unstructured":"Saner, F. H., Canbay, A., Gerken, G. & Broelsch, C. E. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome. Expert Rev. Gastroenterol. Hepatol. 1, 207\u2013217 (2007).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201296_CR46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1440-1746.1990.tb01439.x","volume":"5","author":"KW Chiu","year":"1990","unstructured":"Chiu, K. W., Sheen, I. S. & Liaw, Y. F. A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices. J. Gastroenterol. Hepatol. 5, 549\u2013553 (1990).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201296_CR47","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal, A. J.  et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134, 1360\u20131368 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR48","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Mart\u00edn-Llah\u00ed","year":"2008","unstructured":"Mart\u00edn-Llah\u00ed, M.  et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134, 1352\u20131359 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","volume":"55","author":"TD Boyer","year":"2011","unstructured":"Boyer, T. D.  et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J. Hepatol. 55, 315\u2013321 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.23283","volume":"51","author":"A Nazar","year":"2010","unstructured":"Nazar, A.  et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 51, 219\u2013226 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ncpgasthep0680","volume":"4","author":"F Wong","year":"2007","unstructured":"Wong, F. Drug insight: the role of albumin in the management of chronic liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 43\u201351 (2007).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"BFnrgastro201296_CR52","first-page":"307","volume":"16","author":"G Nilsson","year":"1990","unstructured":"Nilsson, G., Lindblom, P., Ohlin, M., Berling, R. & Vernersson, E. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp. Clin. Res. 16, 307\u2013314 (1990).","journal-title":"Drugs Exp. Clin. Res."},{"issue":"Suppl.","key":"BFnrgastro201296_CR53","first-page":"378A","volume":"48","author":"P Angeli","year":"2008","unstructured":"Angeli, P.  et al. Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: results of a controlled clinical trial [abstract LB3]. Hepatology 48 (Suppl.), 378A (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR54","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1053\/j.gastro.2009.03.064","volume":"137","author":"AL Gerbes","year":"2009","unstructured":"Gerbes, A. L., Huber, E. & G\u00fclberg, V. Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to i.v. bolus administration. Gastroenterology 137, 1179\u20131181 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR55","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0168-8278(97)80428-X","volume":"26","author":"A Escorsell","year":"1997","unstructured":"Escorsell, A.  et al. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J. Hepatol. 26, 621\u2013627 (1997).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jhep.2011.02.002","volume":"55","author":"S Piano","year":"2011","unstructured":"Piano, S.  et al. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation? J. Hepatol. 55, 491\u2013496 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR57","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1002\/hep.510290629","volume":"29","author":"P Angeli","year":"1999","unstructured":"Angeli, P.  et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29, 1690\u20131697 (1999).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/hep.20262","volume":"40","author":"F Wong","year":"2004","unstructured":"Wong, F., Pantea, L. & Sniderman, K. Midodrine, octreotide, albumin and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40, 55\u201364 (2004).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR59","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","volume":"52","author":"E Esrailian","year":"2007","unstructured":"Esrailian, E., Pantangco, E. R., Kyulo, N. L., Hu, K. Q. & Runyon, B. A. Octreotide\/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig. Dis. Sci. 52, 742\u2013748 (2007).","journal-title":"Dig. Dis. Sci."},{"issue":"Suppl. 1","key":"BFnrgastro201296_CR60","first-page":"1426A","volume":"54","author":"M Cavallin","year":"2011","unstructured":"Cavallin, M.  et al. Terlipressin and albumin vs. midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by the Italian Association for the Study of the Liver [abstract LB-2]. Hepatology 54 (Suppl. 1), 1426A (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR61","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/TP.0b013e31821690bf","volume":"91","author":"JP Rice","year":"2011","unstructured":"Rice, J. P., Skagen, C. & Said, A. Liver transplant outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin. Transplantation 91, 1141\u20131147 (2011).","journal-title":"Transplantation"},{"key":"BFnrgastro201296_CR62","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","volume":"103","author":"P Sharma","year":"2008","unstructured":"Sharma, P., Kumar, A., Shrama, B. C. & Sarin, S. K. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am. J. Gastroenterol. 103, 1689\u20131697 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201296_CR63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","volume":"47","author":"C Alessandria","year":"2007","unstructured":"Alessandria, C.  et al. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J. Hepatol. 47, 499\u2013505 (2007).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR64","doi-asserted-by":"publisher","unstructured":"Singh, V.  et al. Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome: a randomized study. J. Hepatol. \n                    http:\/\/dx.doi.org\/10.1016\/j.jhep.2012.01.012\n                    \n                  .","DOI":"10.1016\/j.jhep.2012.01.012"},{"key":"BFnrgastro201296_CR65","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/hep.23286","volume":"51","author":"LL Gluud","year":"2010","unstructured":"Gluud, L. L., Christensen, K., Christensen, E. & Krag, A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 51, 576\u2013584 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR66","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","volume":"25","author":"SV Sagi","year":"2010","unstructured":"Sagi, S. V., Mittal, S., Kasturi, K. S. & Sood, G. K. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J. Gastroenterol. Hepatol. 25, 880\u2013885 (2010).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201296_CR67","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hep.510280219","volume":"28","author":"M Guevara","year":"1998","unstructured":"Guevara, M.  et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 28, 416\u2013422 (1998).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR68","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(97)24010-9","volume":"349","author":"KA Brensing","year":"1997","unstructured":"Brensing, K. A.  et al. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 349, 697\u2013698 (1997).","journal-title":"Lancet"},{"key":"BFnrgastro201296_CR69","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1136\/gut.47.2.288","volume":"47","author":"KA Brensing","year":"2000","unstructured":"Brensing, K. A.  et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 47, 288\u2013295 (2000).","journal-title":"Gut"},{"key":"BFnrgastro201296_CR70","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0168-8278(02)00334-3","volume":"38","author":"R Jalan","year":"2003","unstructured":"Jalan, R.  et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J. Hepatol. 38, 24\u201331 (2003).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR71","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/j.transproceed.2005.06.048","volume":"37","author":"C Di Campli","year":"2005","unstructured":"Di Campli, C.  et al. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure. Transplant. Proc. 37, 2547\u20132550 (2005).","journal-title":"Transplant. Proc."},{"key":"BFnrgastro201296_CR72","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/lv.2000.6355","volume":"6","author":"SR Mitzner","year":"2000","unstructured":"Mitzner, S. R.  et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl. 6, 277\u2013286 (2000).","journal-title":"Liver Transpl."},{"key":"BFnrgastro201296_CR73","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/gut.2008.174615","volume":"59","author":"F Wong","year":"2010","unstructured":"Wong, F., Raina, N. & Richardson, R. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment. Gut 59, 381\u2013386 (2010).","journal-title":"Gut"},{"key":"BFnrgastro201296_CR74","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","volume":"113","author":"L Ruiz-del-Arbol","year":"1997","unstructured":"Ruiz-del-Arbol, L.  et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 113, 579\u2013586 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR75","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega, R.  et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36, 941\u2013948 (2002).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR76","first-page":"1753","volume":"50","author":"G Testino","year":"2003","unstructured":"Testino, G.  et al. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 50, 1753\u20131755 (2003).","journal-title":"Hepatogastroenterology"},{"key":"BFnrgastro201296_CR77","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","volume":"14","author":"C Alessandria","year":"2002","unstructured":"Alessandria, C., Venon, W. & Marzano, A. Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2. Eur. J. Gastroenterol. Hepatol. 14, 1363\u20131368 (2002).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201296_CR78","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1023\/A:1021763221337","volume":"48","author":"C Cassinello","year":"2003","unstructured":"Cassinello, C.  et al. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig. Dis. Sci. 48, 179\u2013186 (2003).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro201296_CR79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","volume":"124","author":"R Wiesner","year":"2003","unstructured":"Wiesner, R.  et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91\u201396 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR80","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MOT.0b013e328346576c","volume":"16","author":"I Memon","year":"2011","unstructured":"Memon, I. & Klein, C. L. Impact of hepatorenal syndrome and liver transplantation. Curr. Opin. Organ. Transplant. 16, 301\u2013305 (2011).","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"BFnrgastro201296_CR81","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","volume":"40","author":"T Restuccia","year":"2004","unstructured":"Restuccia, T.  et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J. Hepatol. 40, 140\u2013146 (2004).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201296_CR82","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/lt.22433","volume":"17","author":"P Gin\u00e8s","year":"2011","unstructured":"Gin\u00e8s, P. Hepatorenal syndrome, pharmacological therapy, and liver transplantation. Liver Transpl. 17, 1244\u20131246 (2011).","journal-title":"Liver Transpl."},{"key":"BFnrgastro201296_CR83","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","volume":"68","author":"LP Wong","year":"2005","unstructured":"Wong, L. P.  et al. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 68, 362\u2013370 (2005).","journal-title":"Kidney Int."},{"key":"BFnrgastro201296_CR84","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/ndt\/gfi212","volume":"21","author":"PE Marik","year":"2006","unstructured":"Marik, P. E., Wood, K. & Starzl, T. E. The course of type 1 hepatorenal syndrome post liver transplantation. Nephrol. Dial. Transplant. 21, 478\u2013482 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrgastro201296_CR85","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/hep.1840170202","volume":"17","author":"A Hadengue","year":"1993","unstructured":"Hadengue, A.  et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 17, 175\u2013178 (1993).","journal-title":"Hepatology"},{"key":"BFnrgastro201296_CR86","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","volume":"7","author":"CL Davis","year":"2007","unstructured":"Davis, C. L.  et al. Simultaneous liver\u2013kidney transplantation: evaluation to decision making. Am. J. Transplant. 7, 1702\u20131709 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrgastro201296_CR87","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MOT.0b013e328338f638","volume":"15","author":"H Papafragkakis","year":"2010","unstructured":"Papafragkakis, H., Martin, P. & Akalin, E. Combined liver and kidney transplantation. Curr. Opin. Organ. Transplant. 15, 263\u2013268 (2010).","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"BFnrgastro201296_CR88","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/TP.0b013e318168476d","volume":"85","author":"JE Locke","year":"2008","unstructured":"Locke, J. E.  et al. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation 85, 935\u2013942 (2008).","journal-title":"Transplantation"},{"key":"BFnrgastro201296_CR89","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/lt.21149","volume":"13","author":"R Ruiz","year":"2007","unstructured":"Ruiz, R.  et al. Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl. 13, 838\u2013843 (2007).","journal-title":"Liver Transpl."},{"key":"BFnrgastro201296_CR90","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1365-2036.2009.04096.x","volume":"30","author":"M Somsouk","year":"2009","unstructured":"Somsouk, M.  et al. Ascites improves upon serum sodium plus model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease. Aliment. Pharmacol. Ther. 30, 741\u2013748 (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201296_CR91","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/lt.22218","volume":"17","author":"M Somsouk","year":"2011","unstructured":"Somsouk, M., Kornfield, R., Vittinghoff, E., Inadomi, J. M. & Biggins, S. W. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl. 17, 129\u2013136 (2011).","journal-title":"Liver Transpl."},{"key":"BFnrgastro201296_CR92","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez, J.  et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133, 818\u2013824 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR93","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1053\/j.gastro.2010.01.040","volume":"138","author":"D Lebrec","year":"2010","unstructured":"Lebrec, D.  et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology 138, 1755\u20131762 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR94","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1053\/gast.2000.20189","volume":"119","author":"E Akriviadis","year":"2000","unstructured":"Akriviadis, E.  et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119, 1637\u20131648 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201296_CR95","doi-asserted-by":"publisher","unstructured":"Whitfield, K., Rambaldi, A., Wetterslev, J. & Gluud, C. Pentoxifylline for alcoholic hepatitis. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD007339. \n                    http:\/\/dx.doi.org\/10.1002\/14651858.CD007339.pub2\n                    \n                  .","DOI":"10.1002\/14651858.CD007339.pub2"},{"key":"BFnrgastro201296_CR96","first-page":"1766","volume":"25","author":"JR Lake","year":"1993","unstructured":"Lake, J. R.  et al. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant. Proc. 25, 1766\u20131767 (1993).","journal-title":"Transplant. Proc."},{"key":"BFnrgastro201296_CR97","first-page":"1169","volume":"90","author":"L Spahr","year":"1995","unstructured":"Spahr, L.  et al. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am. J. Gastroenterol. 90, 1169\u20131171 (1995).","journal-title":"Am. J. Gastroenterol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2012.96.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2012.96","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2012.96.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:47:23Z","timestamp":1684453643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2012.96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,22]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFnrgastro201296"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2012.96","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,22]]}}}